Literature DB >> 7474155

Gamma interferon is critical for resistance to Theiler's virus-induced demyelination.

M Rodriguez1, K Pavelko, R L Coffman.   

Abstract

Administration of neutralizing monoclonal antibody to gamma interferon increased Theiler's virus-induced demyelination and virus antigen persistence in the spinal cord in susceptible SJL/J mice and completely abrogated resistance such that all C57BL/10SNJ mice developed demyelination. These experiments support the hypothesis that gamma interferon is critically important for resistance to Theiler's virus-induced disease but is not required for myelin destruction.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7474155      PMCID: PMC189655     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

Review 1.  Theiler's murine encephalomyelitis: a model of demyelination and persistence of virus.

Authors:  M Rodriguez; E Oleszak; J Leibowitz
Journal:  Crit Rev Immunol       Date:  1987       Impact factor: 2.214

2.  Mechanism of Theiler's virus-induced demyelination in nude mice.

Authors:  A Rosenthal; R S Fujinami; P W Lampert
Journal:  Lab Invest       Date:  1986-05       Impact factor: 5.662

3.  Mechanism of recovery from acute virus infection. VIII. Treatment of lymphocytic choriomeningitis virus-infected mice with anti-interferon-gamma monoclonal antibody blocks generation of virus-specific cytotoxic T lymphocytes and virus elimination.

Authors:  A Wille; A Gessner; H Lother; F Lehmann-Grube
Journal:  Eur J Immunol       Date:  1989-07       Impact factor: 5.532

4.  Role of natural killer cells as immune effectors in encephalitis and demyelination induced by Theiler's virus.

Authors:  C V Paya; A K Patick; P J Leibson; M Rodriguez
Journal:  J Immunol       Date:  1989-07-01       Impact factor: 5.422

5.  Mapping loci influencing the persistence of Theiler's virus in the murine central nervous system.

Authors:  J F Bureau; X Montagutelli; F Bihl; S Lefebvre; J L Guénet; M Brahic
Journal:  Nat Genet       Date:  1993-09       Impact factor: 38.330

6.  Characterization of Theiler's murine encephalomyelitis virus (TMEV)-specific delayed-type hypersensitivity responses in TMEV-induced demyelinating disease: correlation with clinical signs.

Authors:  R J Clatch; H L Lipton; S D Miller
Journal:  J Immunol       Date:  1986-02-01       Impact factor: 5.422

7.  Partial suppression of Theiler's virus-induced demyelination in vivo by administration of monoclonal antibodies to immune-response gene products (Ia antigens).

Authors:  M Rodriguez; W P Lafuse; J Leibowitz; C S David
Journal:  Neurology       Date:  1986-07       Impact factor: 9.910

8.  Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies.

Authors:  H M Cherwinski; J H Schumacher; K D Brown; T R Mosmann
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

Review 9.  Multiple sclerosis: basic concepts and hypothesis.

Authors:  M Rodriguez
Journal:  Mayo Clin Proc       Date:  1989-05       Impact factor: 7.616

10.  Endogenous gamma interferon produced in central nervous system by systemic infection with Theiler's virus in mice.

Authors:  M Kohanawa; A Nakane; T Minagawa
Journal:  J Neuroimmunol       Date:  1993 Nov-Dec       Impact factor: 3.478

View more
  28 in total

1.  Preferential induction of protective T cell responses to Theiler's virus in resistant (C57BL/6 x SJL)F1 mice.

Authors:  Young-Hee Jin; Hyun Seok Kang; Mani Mohindru; Byung S Kim
Journal:  J Virol       Date:  2010-12-29       Impact factor: 5.103

2.  Transgenic expression of the 3D polymerase inhibits Theiler's virus infection and demyelination.

Authors:  Jason Kerkvliet; Laurie Zoecklein; Louisa Papke; Aleksandar Denic; Allan J Bieber; Larry R Pease; Chella S David; Moses Rodriguez
Journal:  J Virol       Date:  2009-09-16       Impact factor: 5.103

3.  Disassociation between the in vitro and in vivo effects of nitric oxide on a neurotropic murine coronavirus.

Authors:  T E Lane; A D Paoletti; M J Buchmeier
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

4.  Important roles for gamma interferon and NKG2D in gammadelta T-cell-induced demyelination in T-cell receptor beta-deficient mice infected with a coronavirus.

Authors:  Ajai A Dandekar; Katherine O'Malley; Stanley Perlman
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

5.  Injection of the sciatic nerve with TMEV: a new model for peripheral nerve demyelination.

Authors:  Kristen M Drescher; Steven M Tracy
Journal:  Virology       Date:  2006-10-09       Impact factor: 3.616

Review 6.  Neuroimmune interactions in a model of multiple sclerosis.

Authors:  C Jane Welsh; Andrew J Steelman; Wentao Mi; Colin R Young; Ralph Storts; Thomas H Welsh; Mary W Meagher
Journal:  Ann N Y Acad Sci       Date:  2009-02       Impact factor: 5.691

7.  Interleukin 22 is a candidate gene for Tmevp3, a locus controlling Theiler's virus-induced neurological diseases.

Authors:  F Levillayer; M Mas; F Levi-Acobas; M Brahic; J F Bureau
Journal:  Genetics       Date:  2007-05-04       Impact factor: 4.562

Review 8.  Theiler's virus infection: a model for multiple sclerosis.

Authors:  Emilia L Oleszak; J Robert Chang; Herman Friedman; Christos D Katsetos; Chris D Platsoucas
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

9.  Restraint stress fails to render C57BL/6 mice susceptible to Theiler's virus-induced demyelination.

Authors:  Andrew J Steelman; Eric Alford; Colin R Young; Thomas H Welsh; Mary W Meagher; C Jane R Welsh
Journal:  Neuroimmunomodulation       Date:  2009-11-17       Impact factor: 2.492

10.  Theiler's virus persistence and demyelination in major histocompatibility complex class II-deficient mice.

Authors:  M K Njenga; K D Pavelko; J Baisch; X Lin; C David; J Leibowitz; M Rodriguez
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.